Medicines Formulary

Reports

Drug name	NICE TAs	Comments
Eslicarbazepine tablets		ESCA. MHRA - Category 2
Ethosuximide capsules		MHRA - Category 3
Evra (patches)		Umbrella service only - patients with compliance problems and metabolic problems
Exemestane tablets	TA112 - Hormonal therapies for the adjuvant treatment of early oestrogen-receptor-positive breast cancer
Fentanyl patches
Ferric maltol (Feraccru®)	RICaD for Ferric maltol (pdf)	For the treatment of iron deficiency anaemia (IDA) in patients with inflammatory bowel disease (IBD), unable to tolerate other oral iron formulations. Supported by a RICaD
Flash glucose monitoring system (FreeStyle Libre 2®, FreeStyle Libre®)		BSOL CCG Clinical Commissioning Policy: commissioning of flash glucose monitoring for patients with diabetes meeting the NHS England funding criteria
Flecainide injection		Hospital only
Flucitasone inhaler (Flixotide) evohaler 125 / Fluticasone accuhaler 250		For paediatric use only
Fludroxycortide 7.5cm x 200cm tape	TA85 - Frequency of application of topical corticosteroids for atopic eczema

First page
Previous page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
Next page
Last page

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.